Bortezomib Consolidation or Maintenance Following Immunochemotherapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: CALGB/Alliance 50403
- Citation:
- Am. J. Hematol. vol 95 (6) 583-593
- Year:
- 2020
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 9
- Pharmas:
- Millennium
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA233180, UG1CA233327, UG1CA233331, UG1CA233339
- Corr. Author:
- Authors:
- Lawrence D. Kaplan Matthew J. Maurer Wendy Stock Nancy L. Bartlett Noreen Fulton Adam Pettinger John C. Byrd Kristie A. Blum Ann S. LaCasce Eric D. Hsi Yi Tian Liu David W. Scott David Hurd Amy S. Ruppert Francisco Hernandez-Ilizaliturri John P. Leonard Bruce. D. Cheson
- Networks:
- 11030, CA824, CAPITAL, COLUMBUS, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NY158, LAPS-OH007, NC002, NY018, OH070
- Study
- CALGB-50403
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Mantle Cell Lymphoma, Marrow/Stem Cell Transplant, clinical, Clinical Trials, bortezomib, maintenance therapy